Neurobiology of HIV

References

• Adle-Biassette H, Levy Y, Colombel M, Poron F, Natchev S, Keohane C, et al. Neuronal apoptosis in HIV infection in adults. Neuropathol Appl Neurobiol 1995; 21(3)218–227
   PubMed Web of Science ®Google Scholar
• Albright A, Shieh J, Itoh T, Lee B, Pleasure D, O’Connor M, et al. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. Journal of Virology 1999; 73(1)205–213
   PubMedGoogle Scholar
• An SF, Giometto B, Groves M, Miller RF, Beckett AA, Gray F, et al. Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS. Journal of Neuropathol Exp Neurol 1997; 56(11)1262–1268
   PubMedGoogle Scholar
• Araque A, Parpura V, Sanzgiri RP, Haydon PG. Glutamate-dependent astrocyte modulation of synaptic transmission between cultured hippocampal neurons. European Journal of Neuroscience 1998; 10(6)2129–2142
   PubMedGoogle Scholar
• Bachis A, Aden SA, Nosheny RL, Andrews PM, Mocchetti I. Axonal transport of human immunodeficiency virus type 1 envelope protein glycoprotein 120 is found in association with neuronal apoptosis. Journal of Neuroscience 2006; 26(25)6771–6780
   PubMedGoogle Scholar
• Bagsara O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R, Pomerantz RJ. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 1996; 10(6)573–585
   PubMedGoogle Scholar
• Banks WA, Robinson SM, Wolf KM, Bess Jr JW, Arthur LO. Binding, internalization, and membrane incorporation of human immunodeficiency virus-1 at the blood-brain barrier is differentially regulated. Neuroscience 2004; 128(1)143–153
   PubMedGoogle Scholar
• Barks JD, Liu XH, Sun R, Silverstein FS. gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats. Neuroscience 1997; 76(2)397–409
   PubMedGoogle Scholar
• Chana G, Everall I, Crews L, Langford D, Adame A, Grant I, et al. Cognitive deficits and degeneration of interneurons in HIV + methamphetamine users. Neurology 2006; 67: 1486–1489
   PubMed Web of Science ®Google Scholar
• Chen RW, Chuang DM. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. Journal of Biol Chem 1999; 274(10)6039–6042
   PubMed Web of Science ®Google Scholar
• Cherner M, Letendre S, Heaton RK, Durelle J, Marquie-Beck J, Gragg B, et al. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology 2005; 64(8)1343–1347
   PubMed Web of Science ®Google Scholar
• Clarke J, Lake J, Burrell C, Wesselingh S, Gorry P, Li P. Novel pathway of human immunodeficiency virus type 1 uptake and release in astrocytes. Virology 2006; 348: 141–155
   PubMedGoogle Scholar
• Conant K, St Hillaire C, Anderson C, Galey D, Wang J, Nath A. Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases. Journal of Neurovirology 2004; 10(1)21–28
   PubMed Web of Science ®Google Scholar
• Cullen BR. Retroviruses as a systems for the study of nuclear RNA export pathways. Virology 1998; 249: 203–210
   PubMedGoogle Scholar
• Danbolt NC. Glutamate uptake. Progress in Neurobiology 2001; 65(1)1–105
   PubMed Web of Science ®Google Scholar
• Davidson C, AJ, G, Lee T, Ellinwood E. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Research 2001; 36(1)1–22
   Google Scholar
• de Lange EC, Danhof M. Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: Implications of the barriers between blood and brain. Clin Pharmacokinet 2002; 41(10)691–703
   PubMed Web of Science ®Google Scholar
• De Vries HE, Kuiper J, de Boer AG, Van Berkel TJC, Breimer DD. The blood-brain barrier in neuroinflammatory disease. Pharamcological Reviews 1997; 49(2)143–155
   PubMed Web of Science ®Google Scholar
• Deng X, Wang Y, Chou J, Cadet JL. Methamphetamine causes widespread apoptosis in the mouse brain: Evidence from using an improved TUNEL histochemical method. Brain Res Mol Brain Res 2001; 93(1)64–69
   PubMedGoogle Scholar
• DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 2000; 133(6)447–454
   PubMed Web of Science ®Google Scholar
• DiStefano M, Sabri F, Chiodi F. HIV-1 Structural and regulatory proteins and neurotoxicity. The Neurology of AIDS, HE Gendelman, I Grant, IP Everall, SA Lipton, S Swindells. Oxford University Press, New York 2005
   Google Scholar
• Dou H, Morehead J, Bradley J, Gorantla S, Ellison B, Kingsley J, et al. Neuropathologic and neuroinflammatory activities of HIV-1-infected human astrocytes in murine brain. Glia 2006; 54(2)81–93
   PubMedGoogle Scholar
• Dreyer E, Kaiser P, Offermann J, Lipton S. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 1990; 248(4953)364–367
   PubMed Web of Science ®Google Scholar
• Dubois-Dalcq M, Altmeyer R, Chiron M, Wilt S. HIV interactions with cells of the nervous system. Current Opinion Neurobiol 1995; 5(5)647–655
   PubMedGoogle Scholar
• El-Hage N, Gurwell JA, Singh IN, Knapp PE, Nath A, Hauser KF. Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. Glia 2005; 50(2)91–106
   PubMedGoogle Scholar
• Eugenin EA, Osiecki K, Lopez L, Goldstein H, Calderon TM, Berman JW. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: A potential mechanism of HIV-CNS invasion and NeuroAIDS. Journal of Neuroscience 2006; 26(4)1098–1106
   PubMed Web of Science ®Google Scholar
• Everall I, Luthert P, Lantos P. A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia. Journal of Neuropathol Exp Neurol 1993; 52(6)561–566
   PubMedGoogle Scholar
• Everall IP, Bell C, Mallory M, Langford D, Adame A, Rockestein E, et al. Lithium ameliorates HIV-gp120-mediated neurotoxicity. Mol Cell Neurosci 2002; 21(3)493–501
   PubMed Web of Science ®Google Scholar
• Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, et al. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. Brain Pathology 1999; 9(2)209–217
   PubMedGoogle Scholar
• Everall IP, Trillo-Pazos G, Bell C, Mallory M, Sanders V, Masliah E. Amelioration of neurotoxic effects of HIV envelope protein gp120 by fibroblast growth factor: A strategy for neuroprotection. Journal of Neuropathol Exp Neurol 2001; 60(3)293–301
   PubMed Web of Science ®Google Scholar
• Fiala M, Looney DJ, Stins M, Way DD, Zhang L, Gan X, et al. TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Molecular Medicine 1997; 3(8)553–564
   PubMedGoogle Scholar
• Flora G, Lee YW, Nath A, Hennig B, Maragos W, Toborek M. Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain. Exp Neurol 2003; 179(1)60–70
   PubMed Web of Science ®Google Scholar
• Forloni G, Demicheli F, Giorgi S, Bendotti C, Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: Modulation by interleukin-1. Brain Res Mol Brain Res 1992; 16(1–2)128–134
   PubMedGoogle Scholar
• Freed EO, Martin MA. HIVs and their replication. Lippincott Williams & Wilkins, Philadelphia 2001
   Google Scholar
• Ghorpade A, Brichacek B, Bukrinski M. The molecular biology of HIV-1. The Neurology of AIDS, HE Gendelman, I Grant, IP Everall, SA Lipton, S Swindells. Oxford University Press, New York 2005; 2: 17–28
   Google Scholar
• Giometto B, An SF, Groves M, Scaravilli T, Geddes JF, Miller R, et al. Accumulation of beta-amyloid precursor protein in HIV encephalitis: Relationship with neuropsychological abnormalities. Annals of Neurology 1997; 42(1)34–40
   PubMedGoogle Scholar
• Giulian D, Vaca K. Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. Stroke 1993; 24(Suppl.12)I84–90
   PubMedGoogle Scholar
• Giulian D, Vaca K, Noonan CA. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 1990; 250(4987)1593–1596
   PubMed Web of Science ®Google Scholar
• Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. Aids 2005; 19(4)407–411
   PubMed Web of Science ®Google Scholar
• Gurwell JA, Nath A, Sun Q, Zhang J, Martin KM, Chen Y, et al. Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience 2001; 102(3)555–563
   PubMed Web of Science ®Google Scholar
• Hilsabeck RC, Castellon SA, Hinkin CH. Neuropsychological aspects of coinfection with HIV and hepatitis C virus. Clinical Infectious Diseases 2005; 41(Suppl.1)S38–44
   Google Scholar
• Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 2002; 35: 440–446
   PubMed Web of Science ®Google Scholar
• Izquierdo I, Fin C, Schmitz PK, Da Silva RC, Jerusalinsky D, Quillfeldt JA, et al. Memory enhancement by intrahippocampal, intraamygdala, or intraentorhinal infusion of platelet-activating factor measured in an inhibitory avoidance task. Proceedings of the National Academy of Science of the USA 1995; 92(11)5047–5051
   PubMedGoogle Scholar
• Kanmogne GD, Kennedy RC, Grammas P. HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: Possible pathway for HIV entry into the brain and HIV-associated dementia. Journal of Neuropathology and Experimental Neurology 2002; 61(11)992–1000
   PubMed Web of Science ®Google Scholar
• Kanmogne GD, Schall K, Leibhart J, Knipe B, Gendelman HE, Persidsky Y. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: Implication for viral neuropathogenesis. Journal of Cerebral Blood Flow Metabolism 2007; 27(1)123–134
   PubMed Web of Science ®Google Scholar
• Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001; 410(6831)988–994
   PubMed Web of Science ®Google Scholar
• Kedzierska K, Crowe SM. The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Current Med Chem 2002; 9(21)1893–1903
   PubMed Web of Science ®Google Scholar
• Khurdayan VK, Buch S, El-Hage N, Lutz SE, Goebel SM, Singh IN, et al. Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. European Journal of Neuroscience 2004; 19(12)3171–3182
   PubMed Web of Science ®Google Scholar
• Kuczenski R, Everall IP, Crews L, Adame A, Grant I, Masliah E. Escalating dose-multiple binge methamphetamine exposure results in degeneration of the neocortex and limbic system in the rat. Exp Neurol 2007; 207(1)42–51
   PubMed Web of Science ®Google Scholar
• Langford D, Adame A, Grigorian A, Grant I, McCutchan J, Ellis R, et al. Patterns of selective neuronal damage in methamphetamine-user AIDS patients. Journal of Acquired Immune Deficiency Syndrome 2003; 34(5)
   PubMedGoogle Scholar
• Langford D, Grigorian A, Hurford R, Adame A, Crews L, Masliah E. The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons. Journal of Neurovirology 2004; 10: 327–337
   PubMed Web of Science ®Google Scholar
• Lannuzel A, Lledo PM, Lamghitnia HO, Vincent JD, Tardieu M. HIV-1 envelope proteins Gp120 and Gp160 potentiate NMDA-induced [Ca2+](I) increase, alter [Ca2+](I) homeostasis and induce neurotoxicity in human embryonic neurons. European Journal of Neuroscience 1995; 7(11)2285–2293
   PubMed Web of Science ®Google Scholar
• Laskus T, Radkowski M, Jablonska J, Kibler K, Wilkinson J, Adair D, et al. Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood 2004; 103(10)3854–3859
   PubMedGoogle Scholar
• Lee SC, Hatch WC, Liu W, Kress Y, Lyman WD, Dickson DW. Productive infection of human fetal microglia by HIV-1. American Journal of Pathology 1993; 143(4)1032–1039
   PubMedGoogle Scholar
• Letendre S, Paulino AD, Rockenstein E, Adame A, Crews L, Cherner M, et al. Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. Journal of Infectious Diseases 2007; 196(3)361–370
   PubMed Web of Science ®Google Scholar
• Letendre SL, Cherner M, Ellis RJ, Marquie-Beck J, Gragg B, Marcotte T, et al. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: Biological correlates of disease. AIDS 2005; 19(Suppl. 3)S72–78
   PubMed Web of Science ®Google Scholar
• Letendre SL, Woods SP, Ellis RJ, Atkinson JH, Masliah E, van den Brande G, et al. Lithium improves HIV-associated neurocognitive impairment. AIDS 2006; 20(14)1885–1888
   PubMed Web of Science ®Google Scholar
• Liang C, Wainberg MA. The role of Tat in HIV-1 replication: An activator and/or a suppressor?. AIDS Review 2002; 4(1)41–49
   PubMedGoogle Scholar
• Liao YF, Wang BJ, Cheng HT, Kuo LH, Wolfe MS. Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. Journal of Biol Chem 2004; 279(47)49523–49532
   PubMed Web of Science ®Google Scholar
• Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 1991; 7(1)111–118
   PubMed Web of Science ®Google Scholar
• Locardi C, Petrini C, Boccoli G, Testa U, Dieffenbach C, Butto S, et al. Increased human immunodeficiency virus (HIV) expression in chronically infected U937 cells upon in vitro differentiation by hydroxyvitamin D3: Roles of interferon and tumor necrosis factor in regulation of HIV production. Journal of Virology 1990; 64(12)5874–5882
   PubMedGoogle Scholar
• Manji HK, Moore GJ, Chen G. Lithium at 50: Have the neuroprotective effects of this unique cation been overlooked?. Biol Psychiatry 1999; 46(7)929–940
   PubMed Web of Science ®Google Scholar
• Masliah E, Ge N, Mucke L. Pathogenesis of HIV-1 associated neurodegeneration. Critical Review of Neurobiology 1996; 10(1)57–67
   PubMedGoogle Scholar
• Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, et al. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Annals of Neurology 1997; 42(6)963–972
   PubMed Web of Science ®Google Scholar
• McCutchan JA, Letendre S. Pharmacology of antiretroviral drugs in the central nervous system:pharmacokinetics, antiretroviral resistance, and pharmacodynamics. The Neurology of AIDS , HE Gendelman, I Grant, IP Everall, SA Lipton, S Swindells. Oxford University Press, New York 2005; 2: 729–734
   Google Scholar
• Moore JP, Trkola A, Dragic T. Co-receptors for HIV-1 entry. Current Opinion in Immunology 1997; 9(4)551–562
   PubMedGoogle Scholar
• Murdoch DM, Venter WD, Van Rie A, Feldman C. Immune reconstitution inflammatory syndrome (IRIS): Review of common infectious manifestations and treatment options. AIDS Research Therapy 2007; 4: 9
   PubMedGoogle Scholar
• Nath A, Sacktor N. Influence of highly active antiretroviral therapy on persistence of HIV in the central nervous system. Current Opinion in Neurology 2006; 19(4)358–361
   PubMedGoogle Scholar
• Nebuloni M, Pellegrinelli A, Ferri A, Bonetto S, Boldorini R, Vago L, et al. Beta amyloid precursor protein and patterns of HIV p24 immunohistochemistry in different brain areas of AIDS patients. AIDS 2001; 15(5)571–575
   PubMedGoogle Scholar
• Nosheny RL, Bachis A, Aden SA, De Bernardi MA, Mocchetti I. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra. Journal of Neurobiology 2006; 66(12)1311–1321
   Google Scholar
• Nuovo GJ, Gallery F, Macconnell P, Braun A. In-situ detection of polymerase chain reaction-amplified HIV-1 nucleic-acids and tumor-necrosis-factor-alpha RNA in the central-nervous-system. American Journal of Pathology 1994; 144(4)659–666
   PubMedGoogle Scholar
• Parpura V, Basarsky TA, Liu F, Jeftinija K, Jeftinija S, Haydon PG. Glutamate-mediated astrocyte-neuron signalling. Nature 1994; 369(6483)744–747
   PubMed Web of Science ®Google Scholar
• Perry SW, Hamilton JA, Tjoelker LW, Dbaibo G, Dzenko KA, Epstein LG, et al. Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis. Journal of Biol Chem 1998; 273(28)17660–17664
   PubMed Web of Science ®Google Scholar
• Persidsky Y, Limoges J, Rasmussen J, Zheng J, Gearing A, Gendelman HE. Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis. Journal of Neuroimmunology 2001; 114(1–2)57–68
   PubMed Web of Science ®Google Scholar
• Petito CK, Roberts B. Evidence of apoptotic cell death in HIV encephalitis. American Journal of Pathology 1995; 146(5)1121–1130
   PubMed Web of Science ®Google Scholar
• Pfefferbaum A, Rosenbloom MJ, Rohlfing T, Adalsteinsson E, Kemper CA, Deresinski S, et al. Contribution of alcoholism to brain dysmorphology in HIV infection: Effects on the ventricles and corpus callosum. Neuroimage 2006; 33(1)239–251
   PubMed Web of Science ®Google Scholar
• Rackstraw S, Meadway J, Bingham J, Al-Sarraj S, Everall I. An emerging severe leukoencephalopathy: Is it due to HIV disease or highly active antiretroviral therapy?. International Journal of STD AIDS 2006; 17(3)205–207
   PubMedGoogle Scholar
• Radkowski M, Wilkinson J, Nowicki M, Adair D, Vargas H, Ingui C, et al. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: Evidence of replication. Journal of Virology 2002; 76(2)600–608
   PubMed Web of Science ®Google Scholar
• Rempel HC, Pulliam L. HIV-1 Tat inhibits neprilysin and elevates amyloid beta. Aids 2005; 19(2)127–135
   PubMedGoogle Scholar
• Reynolds JL, Mahajan SD, Bindukumar B, Sykes D, Schwartz SA, Nair MP. Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Research 2006; 1123(1)226–236
   PubMedGoogle Scholar
• Rogers TJ, Peterson PK. Opioid G protein-coupled receptors: Signals at the crossroads of inflammation. Trends in Immunology 2003; 24(3)116–121
   PubMedGoogle Scholar
• Rollins BJ. Monocyte chemoattractant protein 1: A potential regulator of monocyte recruitment in inflammatory disease. Molecular Medicine Today 1996; 2(5)198–204
   PubMedGoogle Scholar
• Ryan EL, Morgello S, Isaacs K, Naseer M, Gerits P. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology 2004; 62(6)957–962
   PubMed Web of Science ®Google Scholar
• Shimizu S, Khan MZ, Hippensteel RL, Parkar A, Raghupathi R, Meucci O. Role of the transcription factor E2F1 in CXCR4-mediated neurotoxicity and HIV neuropathology. Neurobiol Dis 2007; 25(1)17–26
   PubMedGoogle Scholar
• Skiest DJ. Focal neurological disease in patients with acquired immunodeficiency syndrome. Clinical Infectious Diseases 2002; 34(1)103–115
   PubMed Web of Science ®Google Scholar
• Smit TK, Brew BJ, Tourtellotte W, Morgello S, Gelman BB, Saksena NK. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment. Journal of Virology 2004; 78(18)10133–10148
   PubMedGoogle Scholar
• Strizki JM, Albright AV, Sheng H, O’Connor M, Perrin L, Gonzalez-Scarano F. Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: Evidence of differential tropism. Journal of Virology 1996; 70(11)7654–7662
   PubMedGoogle Scholar
• Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Annals of Neurology 1996; 39(6)705–711
   PubMedGoogle Scholar
• Teather LA, Packard MG, Bazan NG. Effects of posttraining intrahippocampal injections of platelet-activating factor and PAF antagonists on memory. Neurobiology of Learning and Memory 1998; 70: 349–363
   PubMedGoogle Scholar
• Trillo-Pazos G, Diamanturos A, Rislove L, Menza T, Chao W, Belem P, et al. Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathology 2003; 13(2)144–154
   PubMed Web of Science ®Google Scholar
• Venkataramana A, Pardo CA, McArthur JC, Kerr DA, Irani DN, Griffin JW, et al. Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology 2006; 67(3)383–388
   PubMed Web of Science ®Google Scholar
• Wang J, Gabuzda D. Reconstitution of human immunodeficiency virus-induced neurodegeneration using isolated populations of human neurons, astrocytes, and microglia and neuroprotection mediated by insulin-like growth factors. Journal of Neurovirology 2006; 12(6)472–491
   PubMed Web of Science ®Google Scholar
• Wei H, Qin ZH, Senatorov VV, Wei W, Wang Y, Qian Y, et al. Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease. Neuroscience 2001; 106(3)603–612
   PubMedGoogle Scholar
• Wood LV. Antiretroviral therapy in children. The Neurology of AIDS, HE Gendelman, I Grant, IP Everall, SA Lipton, S Swindells. Oxford University Press, New York 2005; 2
   Google Scholar
• Wynn HE, Brundage RC, Fletcher CV. Clinical implications of CNS penetration of antiretroviral drugs. CNS Drugs 2002; 16(9)595–609
   PubMed Web of Science ®Google Scholar
• Yeh MW, Kaul M, Zheng JL, Nottet HSLM, Thylin M, Gendelman HE, et al. Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of L-cysteine. Journal of Immunology 2000; 164(8)4265–4270
   PubMedGoogle Scholar
• Yuan P, Chen G, Manji HK. Lithium activates the c-Jun NH2-terminal kinases in vitro and in the CNS in vivo. Journal of Immunology 1999; 73(6)2299–2309
   Google Scholar